Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/10495/43085
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Úsuga Úsuga, Franky Alberto | - |
dc.contributor.author | Velásquez Lopera, Margarita María | - |
dc.contributor.author | Quiros Gómez, Oscar Iván | - |
dc.contributor.author | Correa Londoño, Luis Alfonso | - |
dc.date.accessioned | 2024-11-03T13:16:59Z | - |
dc.date.available | 2024-11-03T13:16:59Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0926-9959 | - |
dc.identifier.uri | https://hdl.handle.net/10495/43085 | - |
dc.description.abstract | ABSTRACT: Psoriasis affects the individual, their social and family environment (1,2), comorbidity with human immunodeficiency virus (HIV) could worsen its clinical presentation, an underlying cause of this shame are dysregulation and immunosuppression (3). It has been postulated that gp120 HIV glycoprotein acts as superantigen that activate CD4+ cells, Bcells, and basophils, even it could stimulate expression HLA-DR in keratinocyte, a feasible mechanism for HIV to cause psoriasis in previously non-psoriatic individuals (3). The prevalence of psoriasis-HIV is between 2.5% to 5%. Psoriasis can be the initial cutaneous manifestation of an HIV infection, and it is present during all phases of disease including AIDS. Vulgar, guttate and erythrodermic psoriasis are most frequently associated with HIV (3). Objectives: To describe the clinical and histopathological characteristics | spa |
dc.format.extent | 2 páginas | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.publisher | Wiley | spa |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | spa |
dc.rights | info:eu-repo/semantics/openAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | * |
dc.title | Clinical and histopathological characteristics of HIV-psoriasis cases | spa |
dc.type | info:eu-repo/semantics/conferenceObject | spa |
dc.publisher.group | Centro de de Investigaciones Dermatológicas | spa |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 1468-3083 | - |
oaire.citationtitle | Journal of the European Academy of Dermatology and Venereology | spa |
oaire.citationstartpage | 59 | spa |
oaire.citationendpage | 60 | spa |
oaire.citationvolume | 33 | spa |
oaire.citationissue | Suplemento 3 | spa |
dc.rights.creativecommons | https://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
dc.publisher.place | Oxford, Inglaterra | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6670 | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/EC | spa |
dc.type.local | Póster de conferencia | spa |
dc.subject.decs | Psoriasis | - |
dc.subject.decs | Histología | - |
dc.subject.decs | Histology | - |
dc.subject.decs | VIH | - |
dc.subject.decs | HIV | - |
dc.description.researchgroupid | COL0130733 | spa |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D011565 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D006653 | - |
dc.subject.meshuri | https://id.nlm.nih.gov/mesh/D006678 | - |
dc.relation.ispartofjournalabbrev | J. Eur. Acad. Dermatol. Venereol. | spa |
Aparece en las colecciones: | Artículos de Revista en Ciencias Médicas |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
UsugaFranky_2019_Clinical_Histopathological.pdf | Póster de conferencia | 149.5 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons